Microbiology and Epidemiology of Oral Yeast Colonization in Hemopoietic Progenitor Cell Transplant Recipients

Overview

Journal Oral Surg Oral Med Oral Pathol Oral Radiol

Publisher Elsevier

Specialties Dentistry
General Surgery

Date 2013 Jan 15

PMID 23312542

Citations 8

Authors

Steven D Westbrook

William R Kirkpatrick

Nathan P Wiederhold

Cesar O Freytes

Juan J Toro

Thomas F Patterson

Spencer W Redding

Affiliations

Soon will be listed here.

Abstract

Objective: We monitored the epidemiology and microbiology of oral yeast colonization in patients undergoing hemopoietic progenitor cell transplantation (HPCT) to examine associations between yeast colonization and oral mucositis.

Study Design: One hundred twenty-one consecutive HPCT patients were sampled for oral yeasts prior to fluconazole (FLC) prophylaxis, at transplantation, and weekly until discharge. Clinical oral mucositis screenings were performed triweekly.

Results: Yeast colonization was evident at 216 of 510 total visits. Candida albicans and Candida glabrata were the predominant organisms. Eight patients showed elevated minimal inhibitory concentrations to FLC. One patient developed fungal septicemia. Patients with oral mucositis assessment scale scores <20 had higher colonization rates than those with higher scores.

Conclusions: FLC is effective in controlling a variety of oral yeasts in HPCT recipients. FLC-resistant yeasts do emerge and can be the source of fungal sepsis. A positive association was not shown between yeast colonization and the presence or severity of oral mucositis.

Citing Articles

Exploring oral candidiasis among cancer patients undergoing chemotherapy in eastern Iran.

Pagheh A, Kardan F, Ghojoghi A, Sebzari A, Erfaninejad M, Askari P Iran J Microbiol. 2024; 16(6):803-811.

PMID: 39737361 PMC: 11682546. DOI: 10.18502/ijm.v16i6.17259.

Model of Chemotherapy-associated Mucositis and Oral Opportunistic Infections.

Sobue T, Bertolini M, Thompson A, Dongari-Bagtzoglou A Bio Protoc. 2021; 9(21):e3411.

PMID: 33654911 PMC: 7853999. DOI: 10.21769/BioProtoc.3411.

Molecular characterization of fungi causing colonization and infection in organ transplant recipients: A one-year prospective study.

Zarei F, Jamal Hashemi S, Salehi M, Mahmoudi S, Zibafar E, Ahmadinejad Z Curr Med Mycol. 2020; 6(1):30-35.

PMID: 32420505 PMC: 7217253. DOI: 10.18502/cmm.6.1.2505.

Integrated Analysis of Clinical and Microbiome Risk Factors Associated with the Development of Oral Candidiasis during Cancer Chemotherapy.

Diaz P, Hong B, Dupuy A, Choquette L, Thompson A, Salner A J Fungi (Basel). 2019; 5(2).

PMID: 31200520 PMC: 6617088. DOI: 10.3390/jof5020049.

and : the effect on wound closure .

Haverman T, Laheij A, de Soet J, de Lange J, Rozema F J Oral Microbiol. 2017; 9(1):1328266.

PMID: 28748033 PMC: 5508356. DOI: 10.1080/20002297.2017.1328266.

References

Redding S, Marr K, Kirkpatrick W, Coco B, Patterson T . Candida glabrata sepsis secondary to oral colonization in bone marrow transplantation. Med Mycol. 2004; 42(5):479-81. DOI: 10.1080/13693780410001731574. View

Wirk B, Wingard J . Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients. Mycopathologia. 2009; 168(6):299-311. DOI: 10.1007/s11046-009-9188-6. View

Copelan E . Hematopoietic stem-cell transplantation. N Engl J Med. 2006; 354(17):1813-26. DOI: 10.1056/NEJMra052638. View

Epstein J, Hancock P, Nantel S . Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003; 96(2):154-63. DOI: 10.1016/s1079-2104(03)00296-8. View

Jones J, Qazilbash M, Shih Y, Cantor S, Cooksley C, Elting L . In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient Sample. Cancer. 2008; 112(5):1096-105. DOI: 10.1002/cncr.23281. View

Westbrook S, Kirkpatrick W, Freytes C, Toro J, Bernardo S, Patterson T . Candida krusei sepsis secondary to oral colonization in a hemopoietic stem cell transplant recipient. Med Mycol. 2007; 45(2):187-90. DOI: 10.1080/13693780601164306. View

Patterson T, Revankar S, Kirkpatrick W, Dib O, Fothergill A, Redding S . Simple method for detecting fluconazole-resistant yeasts with chromogenic agar. J Clin Microbiol. 1996; 34(7):1794-7. PMC: 229117. DOI: 10.1128/JCM.34.7.1794-1797.1996. View

Rex J, Pfaller M, Galgiani J, Bartlett M, Espinel-Ingroff A, Ghannoum M . Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility.... Clin Infect Dis. 1997; 24(2):235-47. DOI: 10.1093/clinids/24.2.235. View

Marr K, Bow E, Chiller T, Maschmeyer G, Ribaud P, Segal B . Fungal infection prevention after hematopoietic cell transplantation. Bone Marrow Transplant. 2009; 44(8):483-7. DOI: 10.1038/bmt.2009.259. View

10.

Laheij A, de Soet J, von dem Borne P, Kuijper E, Kraneveld E, van Loveren C . Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients. Support Care Cancer. 2012; 20(12):3231-40. PMC: 3480583. DOI: 10.1007/s00520-012-1463-2. View

11.

Kontoyiannis D, Marr K, Park B, Alexander B, Anaissie E, Walsh T . Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010; 50(8):1091-100. DOI: 10.1086/651263. View

12.

Blijlevens N, Schwenkglenks M, Bacon P, DAddio A, Einsele H, Maertens J . Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group. J Clin Oncol. 2008; 26(9):1519-25. DOI: 10.1200/JCO.2007.13.6028. View

13.

Goodman J, Winston D, Greenfield R, Chandrasekar P, Fox B, Kaizer H . A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med. 1992; 326(13):845-51. DOI: 10.1056/NEJM199203263261301. View

14.

Epstein J, Raber-Durlacher J, Raber-Drulacher J, Wilkins A, Chavarria M, Myint H . Advances in hematologic stem cell transplant: an update for oral health care providers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009; 107(3):301-12. DOI: 10.1016/j.tripleo.2008.12.006. View

15.

Keefe D, Schubert M, Elting L, Sonis S, Epstein J, Raber-Durlacher J . Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer. 2007; 109(5):820-31. DOI: 10.1002/cncr.22484. View

16.

Westbrook S, Wiederhold N, Vallor A, Kotara S, Bernardo S, Lee S . Loss of in vitro resistance in Candida glabrata following discontinuation of fluconazole prophylaxis in a hematopoietic stem cell transplantation patient. Med Mycol. 2010; 48(3):557-60. PMC: 2856480. DOI: 10.3109/13693780903213504. View

17.

Sonis S, Elting L, Keefe D, Peterson D, Schubert M, Hauer-Jensen M . Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004; 100(9 Suppl):1995-2025. DOI: 10.1002/cncr.20162. View

18.

Sonis S, Eilers J, Epstein J, Leveque F, Liggett Jr W, Mulagha M . Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer. 1999; 85(10):2103-13. DOI: 10.1002/(sici)1097-0142(19990515)85:10<2103::aid-cncr2>3.0.co;2-0. View